These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 22975663)
1. A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy. Su J; Zhu S; Liu Z; Li J; Shen W; Li R Am J Ther; 2014; 21(5):371-6. PubMed ID: 22975663 [TBL] [Abstract][Full Text] [Related]
2. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy. Su J; Zhu S; Liu Z; Jing S; Shen W; Li J Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457 [TBL] [Abstract][Full Text] [Related]
3. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study. El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639 [TBL] [Abstract][Full Text] [Related]
4. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer. Sas-Korczynska B; Sokolowski A; Korzeniowski S Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy]. Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978 [TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy. Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L J BUON; 2015; 20(1):146-57. PubMed ID: 25778310 [TBL] [Abstract][Full Text] [Related]
7. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma. Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer. Go SI; Keam B; Kim TM; Lee SH; Kim DW; Kim HJ; Wu HG; Chung DH; Heo DS Clin Lung Cancer; 2014 Mar; 15(2):e1-6. PubMed ID: 24356090 [TBL] [Abstract][Full Text] [Related]
9. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031 [TBL] [Abstract][Full Text] [Related]
10. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients]. Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984 [TBL] [Abstract][Full Text] [Related]
11. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357 [TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study. Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518 [TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
14. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer. Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung]. Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076 [TBL] [Abstract][Full Text] [Related]
16. Hypofractionated conformal radiotherapy in combination with chemotherapy in limited disease small cell lung cancer patients. Socha J; Guzowska A; Tyc-Szczepaniak D; Szczęsna A; Kępka L Pneumonol Alergol Pol; 2014; 82(2):105-15. PubMed ID: 24615194 [TBL] [Abstract][Full Text] [Related]
17. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Sher DJ; Koshy M; Liptay MJ; Fidler MJ Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108 [TBL] [Abstract][Full Text] [Related]
18. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy. Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558 [TBL] [Abstract][Full Text] [Related]
19. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer. Kamath SS; McCarley DL; Zlotecki RA Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169 [TBL] [Abstract][Full Text] [Related]
20. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response. Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]